Search

everythinglearnresearchcommunity

for

Search:↓

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

Bimatoprost helped eyelash growth in nearly half of the patients with a type of eyelash hair loss.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Alopecia Areata might be linked to Crohn's disease.

Oral isotretinoin effectively treats yellow facial papules in frontal fibrosing alopecia patients.

Trichoscopy can effectively tell apart tinea capitis and alopecia areata in children by looking for specific hair shapes.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.